FindTrial
Sign In

Investigation of efficacy of Lactobacillus tablets to rectal and vaginal flora in Japanese postmenopausal women

Investigation of efficacy of Lactobacillus tablets to rectal and vaginal flora in Japanese postmenopausal women - Effect of Lactobacillus tablets to rectal and vaginal flora

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025601
Enrollment
50
Registered
2017-01-10
Start date
2016-10-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Lactobacillus (Rabure:Kagome) is taken 1 capsule a day for 30 days

Sponsors

Okayama University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1)Postmenopausal women 2)The presence or absence of the urinary tract basis disease is irrelevant. 3)Outpatient

Exclusion criteria

Exclusion criteria: 1)Patients who already have urinary tract infection 2)Patients requiring urological treatment due to urolithiasis, hydronephrosis, urinary tract tumors, etc. 3)Urethral catheter indwelling patient 4)Patients with poor control, severe underlying diseases and complications 5)Allergic patients of lactic acid bacteriaproducts 6)Patient deemed inappropriate

Design outcomes

Primary

MeasureTime frame
Change of rectal and vaginal flora after administration of Lactobacillus tablets—

Secondary

MeasureTime frame
If participants suffer from urinary tract infection during administration of Lactobacillus tablets, bacterial isolates will be examined whether the isolates is from rectum or vagina.—

Countries

Japan

Contacts

Public ContactKouichirou Wada

Okayama University Graduate School of Medicine,Dentistry and Phaemaceutical SciencesHospital Department of Urology

gmd17055@s.okadai.jp086-235-7287

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026